Checkpoint Inhibitor–Associated Autoimmune Diabetes Is Distinct From Type 1 Diabetes von Tsang, Venessa H M, McGrath, Rachel T, Clifton-Bligh, Roderick J, Scolyer, Richard A, Jakrot, Valerie, Guminski, Alexander D, Long, Georgina V, Menzies, Alexander M

Volltext

Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study von Long, Georgina V, Atkinson, Victoria, Lo, Serigne, Sandhu, Shahneen, Guminski, Alexander D, Brown, Michael P, Wilmott, James S, Edwards, Jarem, Gonzalez, Maria, Scolyer, Richard A, Menzies, Alexander M, McArthur, Grant A

Volltext

Predicting response to IL-2 therapy for metastatic melanoma von Guminski, Alexander D, Thompson, John F

Volltext

Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy von Naidoo, Jarushka, Wang, Xuan, Woo, Kaitlin M, Iyriboz, Tunc, Halpenny, Darragh, Cunningham, Jane, Chaft, Jamie E, Segal, Neil H, Callahan, Margaret K, Lesokhin, Alexander M, Rosenberg, Jonathan, Voss, Martin H, Rudin, Charles M, Rizvi, Hira, Hou, Xue, Rodriguez, Katherine, Albano, Melanie, Gordon, Ruth-Ann, Leduc, Charles, Rekhtman, Natasha, Harris, Bianca, Menzies, Alexander M, Guminski, Alexander D, Carlino, Matteo S, Kong, Benjamin Y, Wolchok, Jedd D, Postow, Michael A, Long, Georgina V, Hellmann, Matthew D

Volltext

Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial von Long, Georgina V, Atkinson, Victoria, Cebon, Jonathan S, Jameson, Michael B, Fitzharris, Bernie M, McNeil, Catriona M, Hill, Andrew G, Ribas, Antoni, Atkins, Michael B, Thompson, John A, Hwu, Wen-Jen, Hodi, F Stephen, Menzies, Alexander M, Guminski, Alexander D, Kefford, Richard, Kong, Benjamin Y, Tamjid, Babak, Srivastava, Archana, Lomax, Anna J, Islam, Mohammed, Shu, Xinxin, Ebbinghaus, Scot, Ibrahim, Nageatte, Carlino, Matteo S

Volltext

Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study von McLean, Luke S, Lim, Annette M, Bressel, Mathias, Lee, Jenny, Ladwa, Rahul, Guminski, Alexander D, Hughes, Brett, Bowyer, Samantha, Briscoe, Karen, Harris, Samuel, Kukard, Craig, Zielinski, Rob, Alamgeer, Muhammad, Carlino, Matteo, Mo, Jeremy, Park, John J, Khattak, Muhammad A, Day, Fiona, Rischin, Danny

Volltext

Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian Cancer von SCURR, Lyndee L, GUMINSKI, Alexander D, KENNEDY, Catherine, RIZOS, Helen, HARNETT, Paul R, DE FAZIO, Anna, CHIEW, Yoke-Eng, BALLEINE, Rosemary L, SHARMA, Raghwa, YING LEI, PRYOR, Kylie, WAIN, Gerard V, BRAND, Alison, BYTH, Karen

Volltext

Long-term Follow-up of Standard-Dose Pembrolizumab Plus Reduced-Dose Ipilimumab in Patients with Advanced Melanoma: KEYNOTE-029 Part 1B von Carlino, Matteo S, Menzies, Alexander M, Atkinson, Victoria, Cebon, Jonathan S, Jameson, Michael B, Fitzharris, Bernard M, McNeil, Catriona M, Hill, Andrew G, Ribas, Antoni, Atkins, Michael B, Thompson, John A, Hwu, Wen-Jen, Hodi, F Stephen, Guminski, Alexander D, Kefford, Richard, Wu, Haiyan, Ibrahim, Nageatte, Homet Moreno, Blanca, Long, Georgina V

Volltext

MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinoma von Guminski, Alexander D., Balleine, Rosemary L., Chiew, Yoke-Eng, Webster, Lucy R., Tapner, Michael, Farrell, Geoffrey C., Harnett, Paul R., deFazio, Anna

Volltext

Genomic Profiling of Metastatic Basal cell Carcinoma Reveals Candidate Drivers of Disease and Therapeutic Targets von Vergara, Ismael A., Aivazian, Karina, Carlino, Matteo S., Guminski, Alexander D., Maher, Nigel G., Shannon, Kerwin F., Ch’ng, Sydney, Saw, Robyn P.M., Long, Georgina V., Wilmott, James S., Scolyer, Richard A.

Volltext

Characteristics and outcomes of oncology unit patients requiring admission to an Australian intensive care unit von Tan, Aaron C., Jacques, Sarah K., Oatley, Meredith, Guminski, Alexander D.

Volltext

Survival and prognostic factors for patients with melanoma brain metastases in the era of modern systemic therapy von Tio, Martin, Wang, Xuan, Carlino, Matteo S., Shivalingam, Brindha, Fogarty, Gerald B., Guminski, Alexander D., Lo, Serigne, Hong, Angela M., Menzies, Alexander M., Long, Georgina V.

Volltext

Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes” von Tsang, Venessa H M, McGrath, Rachel T, Clifton-Bligh, Roderick J, Scolyer, Richard A, Jakrot, Valerie, Guminski, Alexander D, Long, Georgina V, Menzies, Alexander M

Volltext

Health-related quality of life in patients with melanoma brain metastases treated with immunotherapy von Thompson, Jake R, Lai-Kwon, Julia, Morton, Rachael L, Guminski, Alexander D, Gonzalez, Maria, Atkinson, Victoria, Sandhu, Shahneen, Brown, Michael P, Menzies, Alexander M, McArthur, Grant A, Lo, Serigne N, Long, Georgina V, Bartula, Iris

Volltext

Cisplatin treatment induces a transient increase in tumorigenic potential associated with high interleukin-6 expression in head and neck squamous cell carcinoma von Poth, Kim J, Guminski, Alexander D, Thomas, Gethin P, Leo, Paul J, Jabbar, Ibtissam A, Saunders, Nicholas A

Volltext

Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomise... von Rozeman, Elisa A, Menzies, Alexander M, van Akkooi, Alexander C J, Adhikari, Chandra, Bierman, Carolien, van de Wiel, Bart A, Scolyer, Richard A, Krijgsman, Oscar, Sikorska, Karolina, Eriksson, Hanna, Broeks, Annegien, van Thienen, Johannes V, Guminski, Alexander D, Acosta, Alex Torres, ter Meulen, Sylvia, Koenen, Anne Miek, Bosch, Linda J W, Shannon, Kerwin, Pronk, Loes M, Gonzalez, Maria, Ch'ng, Sydney, Grijpink-Ongering, Lindsay G, Stretch, Jonathan, Heijmink, Stijn, van Tinteren, Harm, Haanen, John B A G, Nieweg, Omgo E, Klop, Willem M C, Zuur, Charlotte L, Saw, Robyn P M, van Houdt, Winan J, Peeper, Daniel S, Spillane, Andrew J, Hansson, Johan, Schumacher, Ton N, Long, Georgina V, Blank, Christian U

Volltext

Abstract CT177: SQ3370 in advanced solid tumors: Interim phase 1 results von Chawla, Sant P., Batty, Kathleen, Bhadri, Vivek, Bui, Nam, Guminski, Alexander D., Oneto, Jose M. Mejia, Srinivasan, Sangeetha, Strauss, James F., Subbiah, Vivek, Weiss, Mia C., Wilson, Rosalind, Yee, Nathan A., Zacharian, Michael, Kwatra, Vineet

Volltext

Scientists and clinicians test their metal–back to the future with platinum compounds von Guminski, Alexander D, Harnett, Paul R, deFazio, Anna

Volltext

Chemotherapy and biological agents in the clinical management of head and neck squamous cell carcinoma von AD Guminski

Volltext

Sequential 177LuLu-PSMA-617 and docetaxel versus docetaxel in patients with metastatic hormone-sensitive prostate cancer (UpFrontPSMA): a multicentre, open-label, randomised, phase... von Azad, Arun A, Bressel, Mathias, Tan, Hsiang, Voskoboynik, Mark, Suder, Aneta, Weickhardt, Andrew J, Guminski, Alexander, Francis, Roslyn J, Saghebi, Javad, Dhiantravan, Nattakorn, Joshua, Anthony M, Emmett, Louise, Horvath, Lisa, Murphy, Declan G, Hsiao, Edward, Balakrishnar, Bavanthi, Lin, Peter, Redfern, Andrew, Macdonald, William, Ng, Siobhan, Lee, Sze-Ting, Pattison, David A, Nadebaum, David, Kirkwood, Ian D, Hofman, Michael S

Volltext